covid-19-disease

Documents about covid-19-disease

• Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors#1454546ClinicalTrials.gov
• Neonatal Complications of Coronavirus Disease (COVID-19)#866990ClinicalTrials.gov
• Covid-19#1253437Open Library
• Attitude of Healthcare providers to COVID-19 disease prevention–Personal risk perception and vaccine uptake#341630University of Ibadan Institutional Repository
• Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population#1429670ClinicalTrials.gov
• Austrian COVID-19 Registry#870954ClinicalTrials.gov
• Impact of COVID-19 on health professionals’ education in Eastern Mediterranean Region#649911WHO IRIS
• Corticosteroid Therapy in Pulmonary Sequelae of Covid-19#980516ClinicalTrials.gov
• A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much Money People Spend on Healthcare for COVID-19#918557ClinicalTrials.gov
• Post caesarean section complications in women infected with COVID-19 disease#275860OpenUCT
• COVID-19 Vaccine Response in Sickle Cell Disease#1245630ClinicalTrials.gov
• UNAIR Inactivated COVID-19 Vaccine as Homologue Booster (Immunobridging Study)#845087ClinicalTrials.gov
• ImmuneSense™ COVID-19 Study#1307222ClinicalTrials.gov
• Factors Affecting Mortality in Covid-19 Disease#1073622ClinicalTrials.gov
• Spread and Course of COVID-19 Infections#1185763ClinicalTrials.gov
• Impact of Covid-19 in Congenital Heart Disease#842553ClinicalTrials.gov
• Waiting to exhale : COVID-19, asthma and COPD#649267University of Pretoria Repository
• Cardiorespiratory Exercise & Chinese Medicine for Rehabilitation of Discharged Coronavirus Disease (COVID-19) Patients#1231678ClinicalTrials.gov
• Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients#830009ClinicalTrials.gov
• Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons [German: Prophylaxe Der COVID-19-Erkrankung Mit Ivermectin Bei COVID-19 Kontaktpersonen]#875251ClinicalTrials.gov
• COVID-19 Vaccination Hesitancy in Adults With Sickle Cell Disease#208269ClinicalTrials.gov
• Clinical Study of Tanshinone Capsules Against COVID-19#123504ClinicalTrials.gov
• Pericardial Histopathology and COVID-19 Seropositivity#966506ClinicalTrials.gov
• LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia#1029794ClinicalTrials.gov
• Tafenoquine in Patients With Mild to Moderate COVID-19#1478042ClinicalTrials.gov
• COVID-19 Echo Study#1094730ClinicalTrials.gov
• Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression#1293317ClinicalTrials.gov
• Survey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 Symptoms#1375967ClinicalTrials.gov
• Predictors of COVID-19 Infection and Disease Progression#1430855ClinicalTrials.gov
• Design and psychometric analysis of the COVID-19 prevention, recognition and home-management self-efficacy scale#948974Repositorio de Universidad Autónoma de Chile.
• A Phase Ⅱ Clinical Trial of Recombinant Corona Virus Disease-19 (COVID-19) Vaccine (Sf9 Cells)#238199ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)#1452382ClinicalTrials.gov
• Tetrandrine Tablets Used in the Treatment of COVID-19#1419594ClinicalTrials.gov
• Corona Virus Disease 2019 Cohort Study#1462835ClinicalTrials.gov
• Cytokine Storm Among Bangladeshi Patients With COVID-19#1496682ClinicalTrials.gov
• Natural History of Coronavirus Disease (COVID-19) in Systemic Autoimmune Diseases#899152ClinicalTrials.gov
• ARB, ACEi, DRi Effects on COVID-19 Course Disease#432778ClinicalTrials.gov
• Retinal Vascular Changes in Patients After Coronavirus Disease 2019 (COVID-19)#826681ClinicalTrials.gov
• Fingolimod in COVID-19#1089228ClinicalTrials.gov
• Immunogenicity After COVID-19 Vaccines in Adapted Schedules#1196427ClinicalTrials.gov
• Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health#1046345ClinicalTrials.gov
• Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)#451509ClinicalTrials.gov
• Aerobic Training for Rehabilitation of Patients With Post Covid-19 Syndrome#1195787ClinicalTrials.gov
• The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19#912937ClinicalTrials.gov
• Systemic Corticosteroids in Treatment of Post-COVID-19 Interstitial Lung Disease#847972ClinicalTrials.gov
• Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).#885231ClinicalTrials.gov
• Superinfection and Hyperinflammatory Phenotype in COVID-19 (Coronavirus Disease 2019) Pneumonia Patients#1195144ClinicalTrials.gov
• Inhaled Interferon α2b for the Treatment of Coronavirus Disease 19 (COVID-19)#1293502ClinicalTrials.gov
• Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)#175006ClinicalTrials.gov
• COVID-19 epidemiological update, edition 169, 15 July 2024#279023WHO IRIS